News
Search results
Showing matches with:
Ludia Bio, a new spin-off company from the UAB to contribute to the development of biosimilars
24 11 2025
The Autonomous University of Barcelona (UAB) has promoted the creation of a new knowledge-based company, spun out of the Department of Pharmacology, Therapeutics and Toxicology, specialising in advising on the development of biosimilar medicines.